EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biocompatibility of Genetically‐Engineered Pig Cornea in Corneal Xenotransplantation: Preliminary In Vitro Study

Seung Hyeun Lee, Chung Young Kim, Jin Suk Ryu, Dong Hee Choi, Chang Ho Yoon, Chung-Gyu Park, Kimyung Choi, Hyunil Kim, Mee Kum Kim

Xenotransplantation · 2025-09 · 32 (5)

DOI: 10.1111/xen.70081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 22.09.2025. Verfasst von Seung Hyeun Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Ocular Regenerative Medicine and Immunology, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Kore…. Hauptthemen laut MEDLINE: Corneal Transplantation, Transplantation, Heterologous, Cornea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We aimed to evaluate biophysical compatibility of corneal endothelial cells in genetically‐engineered (GE) pigs to identify the best candidate for in vivo nonhuman primate (NHP) study and to collect baseline data for future clinical trials from a biological function perspective.

Methods

Triple or quadruple knock‐out (T[Q]KO) pigs with inactivation of α1,3‐galactosyltransferase (GGTA1), cytidine monophosphate‐N‐acetylneuraminic acid hydroxylase (CMAH), β1,4‐N‐acetylgalactosaminyltransferase (β4GalNT2), and/or isoglobotrihexosylceramide synthase (iGB3s) genes were used in combination with insertion of Human( h ) CD55, CD39, CD46, and thrombomodulin (TBM) genes. Twenty‐seven eyeballs obtained from 14 GE pigs were used to evaluate the physical parameters and functional properties as a suitable donor. Corneal endothelial cell density (ECD) was serially measured for 7 days in a preservative solution. Doubling time (DT) for EC proliferation and immunofluorescence staining of corneal endothelial pump channels and tight junctional proteins were evaluated.

Results

Mean age of GE pigs was 11.9 months old and mean central corneal thickness was 718.2 µm. Mean ECD loss/week was significantly higher in GE pigs younger than 6 months, which was 55.1%, while it was 8.8% in GE pigs older than 6 months ( p < 0.001). T(Q)KO/ h CD46/ h TBM cornea showed early severe apoptotic or necrotic changes of endothelial cells, whereas other GE corneas did not. Although the mean DT increased in all GE pigs, it showed no difference between the younger and older groups. ZO‐1, N‐cadherin, ATPase, SLC4A1, and aquaporin 1 were well expressed on endothelial cells regardless of modified gene types.

Conclusion

It suggests that no effect of the added gene was observed on the endothelial cell functional capacities in TKO(QKO) pig corneas, and GE pigs over 6 months old are suitable as corneal transplant donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Corneal TransplantationTransplantation, HeterologousCorneaAnimalsSwineAnimals, Genetically ModifiedHumansEndothelium, CornealGalactosyltransferasesGenetic EngineeringEndothelial CellsHeterografts

Stichwörter der Autor:innen

corneal endothelial cellcorneal xenotransplantationcytidine monophosphate‐N‐acetylneuraminic acid hydroxylase (CMAH)genetically engineered pigthrombomodulinα1,3‐galactosyltransferase (GGTA1)β1,4‐N‐acetylgalactosaminyltransferase (β4GalNT2)

Substanzen

Galactosyltransferases

Autor:innen und Institutionen

  • Laboratory of Ocular Regenerative Medicine and Immunology, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Ophthalmology, Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, Republic of Korea.
  • Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Transplantation Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Microbiology and Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Optipharm, Inc., Cheongju-si, Republic of Korea.

Förderung

  • Korea Health Technology R&D Project
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Lee, S. H., Kim, C. Y., Ryu, J. S., Choi, D. H., Yoon, C. H., Park, C. G., Choi, K., Kim, H., & Kim, M. K. (2025). Biocompatibility of Genetically‐Engineered Pig Cornea in Corneal Xenotransplantation: Preliminary In Vitro Study. Xenotransplantation, 32(5). https://doi.org/10.1111/xen.70081

Vancouver

Lee SH, Kim CY, Ryu JS, Choi DH, Yoon CH, Park CG, et al. Biocompatibility of Genetically‐Engineered Pig Cornea in Corneal Xenotransplantation: Preliminary In Vitro Study. Xenotransplantation. 2025;32(5). doi:10.1111/xen.70081

BibTeX
@article{Lee2025,
  author = {Lee, Seung Hyeun and Kim, Chung Young and Ryu, Jin Suk and Choi, Dong Hee and Yoon, Chang Ho and Park, Chung-Gyu and Choi, Kimyung and Kim, Hyunil and Kim, Mee Kum},
  title = {Biocompatibility of Genetically‐Engineered Pig Cornea in Corneal Xenotransplantation: Preliminary In Vitro Study},
  journal = {Xenotransplantation},
  year = {2025},
  volume = {32},
  number = {5},
  doi = {10.1111/xen.70081}
}
Kostenlos starten →